ESGU vs VHT
iShares MSCI USA ESG Optimized ETF vs Vanguard Health Care ETF
- • VHT has the lower expense ratio at 0.09% vs 0.15% for ESGU.
- • VHT pays a higher dividend yield (1.58%).
Side-by-side metrics
| Metric | ESGU | VHT |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.15% | 0.09% |
Dividend yield Trailing 12-month yield. | 0.94% | 1.58% |
AUM Assets under management — bigger funds are typically more liquid. | $17.75B | $20.39B |
YTD return | 10.32% | 7.21% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.03 | 0.57 |
P/E ratio | 27.11 | 26.41 |
Last price | $164.99 | $305.90 |
Inception | — | — |
Issuer | iShares | Vanguard |
ESGU top holdings
| NVDA | NVIDIA Corp | 7.15% |
| AAPL | Apple Inc | 6.46% |
| MSFT | Microsoft Corp | 4.08% |
| GOOG | Alphabet Inc Class C | 3.54% |
| AMZN | Amazon.com Inc | 3.49% |
| AVGO | Broadcom Inc | 2.64% |
| GOOGL | Alphabet Inc Class A | 2.16% |
| MU | Micron Technology Inc | 1.98% |
| TSLA | Tesla Inc | 1.81% |
| META | Meta Platforms Inc Class A | 1.78% |
VHT top holdings
| LLY | Eli Lilly and Co | 13.99% |
| JNJ | Johnson & Johnson | 8.44% |
| ABBV | AbbVie Inc | 6.07% |
| UNH | UnitedHealth Group Inc | 5.44% |
| MRK | Merck & Co Inc | 4.63% |
| TMO | Thermo Fisher Scientific Inc | 2.88% |
| AMGN | Amgen Inc | 2.86% |
| GILD | Gilead Sciences Inc | 2.63% |
| ISRG | Intuitive Surgical Inc | 2.38% |
| ABT | Abbott Laboratories | 2.35% |
About ESGU
ESGU (iShares MSCI USA ESG Optimized ETF) is US large/mid-cap stocks with favorable ESG ratings. Managed by iShares, the fund carries $17.7B in assets under management, an expense ratio of 0.15%, a dividend yield of 0.94%. Its largest holding is NVIDIA Corp (NVDA), which represents 7.1% of the portfolio. Real Estate is the fund's largest sector exposure at 2.0%.
About VHT
VHT (Vanguard Health Care ETF) is US health care sector stocks. Managed by Vanguard, the fund carries $20.4B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.58%. Its largest holding is Eli Lilly and Co (LLY), which represents 14.0% of the portfolio. Technology is the fund's largest sector exposure at 0.0%.